Mark Strobeck

Mark Strobeck

Directeur Général chez ROCKWELL MEDICAL, INC.

Fortune : 77 238 $ au 31/05/2026

54 ans
Health Technology
Finance
Consumer Services

Profil

Mark Strobeck is President, Chief Executive Officer & Director at Rockwell Medical, Inc. since 2022.
Dr. Strobeck is Chairman at Windtree Therapeutics, Inc. starting in 2025.
Dr. Strobeck is Director at Horse Power For Life since 2012.
Former roles include President, Chief Executive Officer & Director at Corridor Pharmaceuticals, Inc. from 2012 to 2013; Managing Director at Aquilo Partners LP from 2021 to 2022; Chief Operating Officer & Executive Vice President at Assertio Therapeutics, Inc. in 2020; Chief Operating Officer & Executive Vice President at Zyla Life Sciences LLC from 2015 to 2020; Chief Business Officer & Vice President at Topaz Pharmaceuticals, Inc. from 2010 to 2011; Principal at GSK Equity Investments Ltd. from 2004 to 2006; Vice President-Business Development at GlaxoSmithKline, Inc. from 2003 to 2008; Chief Business Officer at Trevena, Inc. from 2008 to 2010.
Other former positions include Director at Novalar Pharmaceuticals, Inc. and Protein Forest, Inc.; Board Observer at Standard BioTools, Inc., Santarus, Inc., and KuDOS Pharmaceuticals Ltd.; Principal at Tanabe Pharma Corp.; Member at Ben Franklin Technology Partners; Chief Operating Officer & Executive Vice President at Assertio Holdings, Inc. Education includes a doctorate from the University of Cincinnati (Ohio) conferred in 1999 and an undergraduate degree from St. Lawrence University conferred in 1993.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2026 103 954 ( 0,26% ) 77 238 $ 31/05/2026
23/07/2025 2 ( 0% ) 0 $ 31/05/2026

Postes actifs de Mark Strobeck

SociétésPosteDébut
ROCKWELL MEDICAL, INC. Directeur Général 01/07/2022
WINDTREE THERAPEUTICS, INC. Président 01/01/2025
Directeur/Membre du Conseil 01/01/2012

Anciens postes connus de Mark Strobeck

SociétésPosteFin
Corporate Officer/Principal 01/06/2022
ASSERTIO HOLDINGS, INC. Directeur des opérations 14/12/2020
Directeur des opérations 14/12/2020
ZYLA LIFE SCIENCES Directeur des opérations 20/05/2020
Directeur Général 01/12/2013
Voir l'expérience en détail de Mark Strobeck

Formation de Mark Strobeck

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Technology Services

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Mark Strobeck
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT